Corporate Info
About Us
Our Values
Founders Story
Milestones
Board of Directors
Awards and Recognition
Quality
Corporate Social Responsibility
Global Presence
Overview
US
Australia
Europe
UK
Germany
Latin America
Chile
Colombia
Emerging Markets
French West Africa
South Africa
East Africa
Philippines
Kazakhstan
R & D
Our Purpose
Research Facilities
Capabilities
Generics
Proprietary
API
Differentiated Products
Bioequivalence Center
Achievements
Manufacturing
Manufacturing Facilities
Regulatory Accreditation
Facility Tour
Our Offerings
Therapies
Anti Infective
Dermatology
Diabetology
Cardiology
Gastroenterology
Osteoporosis
Rheumatology
CNS
Oncology
Urology
Gynaecology
Vitamins, Mineral and Nutrition
Rx Products
Alkem Generics
OTC Product
Patient Corner
Neurological Diseases & Conditions
Neuro - Psychiatry (CNS)
Neuropathic Pain
Epilepsy
Schizophrenia
Major Depressive Disorder
Anxiety Disorder
Post Stroke Spasticity
Bipolar Disorder
Dementia & Alzheimer's Disease
Stroke
Migraine
Cardiovascular Health
Hypertension
Dyslipidemia
Atrial Fibrillation
Heart Failure
Diabetes & Metabolic Disorders
Diabetes
Skin Diseases & Conditions
Acne
Hair Loss
Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Lung Cancer
Ovarian Cancer
Lymphoma: Non Hodgkin Lymphoma (NHL)
Brain Tumor
Multiple Myleoma
Chemotherapy Induced Nausea & Vomiting (CINV)
Bone Health
Osteoporosis
Musculoskeletal Disorder
Ankylosing Spondylitis
Rheumatoid Arthritis
Osteoarthritis
Urologic Diseases
Benign Prostate Hyperplasia
Gastroenterology
Investor Desk
Disclosures under Regulation 46 of LODR
Details Of Business
Policies
Composition of Committees
Shareholding Pattern
Annual Reports
Quarterly Results
Notice of Board Meeting
Annual Returns
Subsidiary Financial Statements
Investor/ Analyst Meet
Conference Call invite
Investor Presentations
Earnings Call
Schedule of Investor/ Analyst Meet
Credit Ratings
Familiarization Programme
Familiarization Programme Policy
Details of Familiarization Programme
Contact Details
Investor Grievance
KMP's for determining materiality
Secretarial Compliance Report
Newspaper advertisements
Disclosure under Regulation 30
Outcome of Board Meeting
Postal Ballot
Annual General Meeting (AGM)
Other Disclosures
Financial Overview
Disclosure on Related Party Transactions
Forms
Dividend Details
CSR Action Plan
Media Room
Press Release
News Updates
Corporate Press Kit
Careers
Quick Links
Ascend Laboratories
Norac Pharma
Enzene
Contact Us
Adverse Event Reporting
Partnership
Global Locations
Key Contacts
To
Top
Investor Desk
Disclosures under Regulation 46 of LODR
Details Of Business
Policies
Composition of Committees
Shareholding Pattern
Annual Reports
Quarterly Results
Notice of Board Meeting
Annual Returns
Subsidiary Financial Statements
Investor/ Analyst Meet
Conference Call invite
Investor Presentations
Earnings Call
Schedule of Investor/ Analyst Meet
Credit Ratings
Familiarization Programme
Familiarization Programme Policy
Details of Familiarization Programme
Contact Details
Investor Grievance
KMP's for determining materiality
Secretarial Compliance Report
Newspaper advertisements
Disclosure under Regulation 30
Outcome of Board Meeting
Postal Ballot
Annual General Meeting (AGM)
Other Disclosures
Financial Overview
Disclosure on Related Party Transactions
Forms
Dividend Details
CSR Action Plan
Media Room
Press Release
News Updates
Corporate Press Kit
Careers
Quick Links
Ascend Laboratories
Ascend is US based wholly owned subsidiary
of Alkem, provides high-quality and cost
effective generics in several therapeutic
areas.
Click To Visit Web Site
Norac Pharma
Norac pharma is a preferred
california-based API contract research
and manufacturing organization.
Click To visit web site
Enzene
Enzene is technology driven
biotechnology company
based in pune, india.
Click To Visit Web Site
Contact Us
Adverse Event Reporting
Partnership
Global Locations
Key Contacts
Corporate Info
About Us
Our Values
Founders Story
Milestones
Board of Directors
Awards and Recognition
Quality
Corporate Social Responsibility
Global Presence
Overview
US
Australia
Europe
UK
Germany
Latin America
Chile
Colombia
Emerging Markets
French West Africa
South Africa
East Africa
Philippines
Kazakhstan
R & D
Our Purpose
Research Facilities
Capabilities
Generics
Proprietary
API
Differentiated Products
Bioequivalence Center
Achievements
Manufacturing
Manufacturing Facilities
Regulatory Accreditation
Facility Tour
Our Offerings
Therapies
Anti Infective
Dermatology
Diabetology
Cardiology
Gastroenterology
Osteoporosis
Rheumatology
CNS
Oncology
Urology
Gynaecology
Vitamins, Mineral and Nutrition
Rx Products
Alkem Generics
OTC Product
Patient Corner
Neurological Diseases & Conditions
Neuro - Psychiatry (CNS)
Neuropathic Pain
Epilepsy
Schizophrenia
Major Depressive Disorder
Anxiety Disorder
Post Stroke Spasticity
Bipolar Disorder
Dementia & Alzheimer's Disease
Stroke
Migraine
Cardiovascular Health
Hypertension
Dyslipidemia
Atrial Fibrillation
Heart Failure
Diabetes & Metabolic Disorders
Diabetes
Skin Diseases & Hair Disorders
Acne
Hair Loss
Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Lung Cancer
Ovarian Cancer
Lymphoma: Non Hodgkin Lymphoma (NHL)
Brain Tumor
Multiple Myleoma
Chemotherapy Induced Nausea & Vomiting (CINV)
Bone Health
Osteoporosis
Musculoskeletal Disorder
Ankylosing Spondylitis
Rheumatoid Arthritis
Osteoarthritis
Urologic Diseases
Benign Prostate Hyperplasia
Gastroenterology
Gastroenterology
Financial Overview
BSE
NSE
Note: The displayed data may not be real time due to streaming delays.
Investor Desk
Financial Overview
Annual Reports
Annual Returns
Subsidiary Financial Statements
Quarterly Results
Investor Presentations
Earnings Call
Investor Grievance
Policies
Composition of Committees
Notice of Board Meeting
Shareholding Pattern
Outcome of Board Meeting
Postal Ballot
Annual General Meeting (AGM)
Other Disclosures
×
Financial Overview
